Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 5 years ago

Possible Interaction: Copper and Disulfiram

supplement:

Copper

Research Papers that Mention the Interaction

“Accordingly, co-treatment with DSF and Cu downregulated the expression of Cyclin D1 and Cyclin A2, whereas this combination upregulated the level of P21 and P27.”
“However, the anti-tumor activity of DSF was significantly enhanced in the presence of Cu in MDS in vitro and in vivo with minimal safety profiles.”
European journal of pharmacology  •  2021  |  View Paper
“Numerous studies have shown that the combination of DSF and copper (DSF/Cu) greatly enhances its antitumor efficacy.”
Drug discovery today  •  2020  |  View Paper
“The enhancement of the anticancer activity by disulfiram (DSF) chelated with copper (DSF/Cu2+) has been investigated recently, while the underlying molecular mechanisms still need to be fully elucidated.”
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie  •  2019  |  View Paper
“ Cu improved the anti‐metastatic activity of DSF , while Cu alone had no effect.”
Journal of cellular and molecular medicine  •  2018  |  View Paper
“Our findings suggest that DSF/Cu reverses microtubule inhibitor resistance in cancer cells by suppressing ALDH2 expression, and Cu improves the activity of DSF.”
Experimental cell research  •  2018  |  View Paper
“ Disulfiram (DSF), an anti-alcoholism drug, is known to elicit cytotoxicity in many cancer cell types in the presence of copper (Cu).”
Cancer letters  •  2016  |  View Paper
“Of these compounds, disulfiram , an off-patent drug previously used to treat alcoholism, in the presence of a copper supplement , showed low nanomolar efficacy in BTICs including those resistant to temozolomide and the highly infiltrative quiescent stem-like population.”
Clinical Cancer Research  •  2016  |  View Paper
“Together, these findings indicate that disulfiram , particularly when administrated in combination with copper , might represent a potential repurposing agent for treatment of adult B-ALL patients, including those clinically characterized by one or more adverse prognostic factors.”
Oncotarget  •  2016  |  View Paper
“ Disulfiram , which exhibits marked tumor inhibition mediated by copper , was encapsulated in lipid nanocapsules modified with TAT peptide (TATp) and pH-triggered sheddable PEG to target cancer cells on the basis of tumor environmental specificity.”
ACS applied materials & interfaces  •  2015  |  View Paper
“Importantly, Cu improved the anti-angiogenic activity of DSF in all these assays, while copper alone had no effect.”
“These results indicate that Cu improves the anti-angiogenic activity of DSF by targeting the EGFR/Src/VEGF signaling pathway, thus providing a rationale for the use of DSF/Cu rather than DSF alone as an angiogenesis inhibitor in clinical applications.”
Cancer letters  •  2015  |  View Paper
Show More